Literature DB >> 11319743

A simple synthetic route to the formation of a block copolymer of poly(lactic-co-glycolic acid) and polylysine for the fabrication of functionalized, degradable structures for biomedical applications.

E B Lavik1, J S Hrkach, N Lotan, R Nazarov, R Langer.   

Abstract

This article documents the formation of a block copolymer of poly(lactic-co-glycolic acid) and polylysine via a simple coupling technique using dicyclohexyl carbodiimide (DCC). The resulting polymer has been characterized via UV-Vis spectroscopy, GPC, (1)H NMR, and elemental analysis, is soluble in a wide variety of solvents, and is easily processable, making the technique a simple and practical one for the formation of functionalized, degradable block copolymers for the fabrication of functionalized structures for biomedical applications. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11319743     DOI: 10.1002/1097-4636(2001)58:3<291::aid-jbm1019>3.0.co;2-n

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  15 in total

1.  Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors.

Authors:  Jiangbing Zhou; Toral R Patel; Michael Fu; James P Bertram; W Mark Saltzman
Journal:  Biomaterials       Date:  2011-10-19       Impact factor: 12.479

2.  High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysine.

Authors:  Jeremy S Blum; W Mark Saltzman
Journal:  J Control Release       Date:  2008-04-16       Impact factor: 9.776

Review 3.  Design opportunities for actively targeted nanoparticle vaccines.

Authors:  Tarek M Fahmy; Stacey L Demento; Michael J Caplan; Ira Mellman; W Mark Saltzman
Journal:  Nanomedicine (Lond)       Date:  2008-06       Impact factor: 5.307

4.  Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy.

Authors:  Athulya Aravind; Yasuhiko Yoshida; Toru Maekawa; D Sakthi Kumar
Journal:  Drug Deliv Transl Res       Date:  2012-12       Impact factor: 4.617

5.  Intravenous hemostatic nanoparticles increase survival following blunt trauma injury.

Authors:  Andrew J Shoffstall; Kristyn T Atkins; Rebecca E Groynom; Matthew E Varley; Lydia M Everhart; Margaret M Lashof-Sullivan; Blaine Martyn-Dow; Robert S Butler; Jeffrey S Ustin; Erin B Lavik
Journal:  Biomacromolecules       Date:  2012-10-08       Impact factor: 6.988

6.  Exogenous modulation of intrinsic optic nerve neuroprotective activity.

Authors:  Sinisa D Grozdanic; Tatjana Lazic; Markus H Kuehn; Matthew M Harper; Randy H Kardon; Young H Kwon; Erin B Lavik; Donald S Sakaguchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-13       Impact factor: 3.117

7.  Using polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNF.

Authors:  James P Bertram; Millicent F Rauch; Kaliq Chang; Erin B Lavik
Journal:  Pharm Res       Date:  2009-11-17       Impact factor: 4.200

8.  The microscopical characterization of membranes poly (L-glycolic-co-lactic acid) with and without added plasticizer: an in vivo study.

Authors:  Luciana Pietro; Débora R M Silva; Maria do Carmo Alberto-Rincon; E A R Duek
Journal:  J Mater Sci Mater Med       Date:  2007-08-15       Impact factor: 3.896

9.  Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibility.

Authors:  James P Bertram; Steven M Jay; Sara R Hynes; Rebecca Robinson; Jason M Criscione; Erin B Lavik
Journal:  Acta Biomater       Date:  2009-05-04       Impact factor: 8.947

10.  Targeted drug delivery to ischemic stroke via chlorotoxin-anchored, lexiscan-loaded nanoparticles.

Authors:  Liang Han; Qiang Cai; Daofeng Tian; Derek K Kong; Xingchun Gou; Zeming Chen; Stephen M Strittmatter; Zuoheng Wang; Kevin N Sheth; Jiangbing Zhou
Journal:  Nanomedicine       Date:  2016-03-30       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.